▼ SELL
10b5-1 Plan
$ Value
$202K
Shares
6,890
Price
$29
Filed
Mar 4
Insider
Name
Parisi Samuel Joseph
Title
VP, Finance (Interim PAO)
CIK
0002010945
Roles
Officer
Transaction Details
Transaction Date
2026-03-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,717
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/7/2025. | Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. | Each restricted stock unit represents a contingent right to receive one ordinary share. | Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.
Filing Info
Parisi Samuel Joseph's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | ALKS | ▼ | $202K |
| 2026-03-02 | ALKS | A | $0 |
| 2026-03-02 | ALKS | A | $0 |
| 2026-02-26 | ALKS | M | — |
| 2026-02-26 | ALKS | F | $25K |
| 2026-02-26 | ALKS | M | — |
| 2026-02-23 | ALKS | M | — |
| 2026-02-23 | ALKS | F | $22K |
| 2026-02-23 | ALKS | M | — |
| 2026-02-19 | ALKS | M | — |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
POPS RICHARD F
Director and CEO, Alkermes plc
|
— | — | 2026-03-02 |
| Lurker Nancy | — | — | 2026-04-11 |
| Cooke Shane | — | $2.1M | 2026-02-02 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $190K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $892K | 2026-04-01 |
|
Reed Joshua
SVP, Chief Financial Officer
|
— | — | 2026-03-02 |
|
Nichols Christian Todd
SVP, Chief Commercial Officer
|
— | $180K | 2026-03-02 |
|
Jackson Blair Curtis
EVP, Chief Operating Officer
|
— | — | 2026-03-02 |
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
|
— | — | 2026-03-02 |